Member Info for imac1

Wow folks here we go I said 150 today perhaps.!!! Well we have 141.5 paid

Auction already

Great day ahead for all invested, those on the sidelines will have to watch another strong day and any potential gains move further away.
134-137 and moving fast

Looking forward to the nice and steady rerate leading up towards our IBS and Covid trial results this month. Anyone for 150 today???

Also Ghia is not the case that SNG is treatment and therefore in your opinion also not a front runner.

Personally I think SNG will do well but 4D could do even better for Covid 19/20/21 let’s wait and see.

32% up ;-)

QD thanks for your response and all though i may be getting ahead of myself with the SNG mention. The mind does boggle if somehow 4D produces a result that no one expected.

If it doesn't close above £1.30 i can certainly seeing it gapping up in the morning to that or more.

I ll say 32% :-) haha

Big Institutional Investment now piling in after today's webinar i reckon. The industry has clicked on to the fact that microbiome can work and this is truly going to flip the whole healthcare system upside down.

I agree Starbuck given the current portfolio if any of the therapeutics make it into the main stream market we are talking a Multi Billion pound company or Takeover target for the big Pharmas.

Grace and WS also the reason i posted was not a ramp was more a heads up that both companies are awaiting exciting news.
GLTA invested in both.

L2 really moving now looking good hear folks still massively undervalued.

Ask moved up looks like we are going higher into the afternoon. ;-)

Webinar just highlighted how professional a company 4D is and lots of potential exciting therapies in the pipeline. Also reaffirms that the company is a leader in the microbiome therapeutics with over 1000 patents/protections filed.

For those aware of SNG they have a drug that requires a Nebuliser to be administered into the lungs for treatment but MRx-4D0004 is an taken as an Oral capsule. So what one do we think will be cheaper to bring to market on mass if successful and approved. SNG made it a headline drug after moving from COPD/Asthma trials when they understood the benefit it could have to Covid symptoms so is that not what 4D have in effect also done up to this point? Currently the only down side is we are behind SNG with trials and have had absolutely no media coverage like they had. SNG now sitting at Mkt Cap of £350M+ while we have released promising results for MRx0158 Keytruda Part A trial and have a further 2 potential Phase II results lined up for the next few weeks. One of which is in fashion (Covid 19) at a Mkt Cap of £150M this could be a massive rerate if we prove either remotely successful. Final point take a look at a company operating in the same field of microbiome therapeutics, NASDAQ listed company Seres Therapeutics (MCRB) Mkt Cap $2.365B yes that is Billion. https://finance.yahoo.com/quote/MCRB/
4D in my opinion is one of the most undervalued shares on LSE and value will win in the end.

Most of us are well aware of the IBS Phase II trial here, but i still feel people have taken their eye of the ball with the Covid 19 Phase II trial also due results for end of Sept.
Here is what the experts had to say about it.
4D's Chief Scientific Officer, Alex Stevenson, commented:
If MRx-4DP0004 is successful in this study it would represent a highly significant breakthrough in the global fight against the novel coronavirus pandemic."

Dr. Dinesh Saralaya (Consultant Respiratory Physician and Associate Director of Research at Bradford Teaching Hospitals NHS Foundation Trust, and the National Institute for Health Research's (NIHR) Clinical Lead for Respiratory industry studies), commented:
"As well as its appropriate mechanism of action, the highly favourable safety profile of MRx-4DP0004 makes it a particularly attractive candidate for COVID-19 patients, and may potentially allow us to prevent or delay their progression to requiring ventilation and intensive care."

So looks like the penny has finally dropped and people are starting to believe in 4D again.
Huge potential and I for one cannot wait for the IBS data to be released. More than just myself who has contacted trial patients it seems.

Coming up can see this settling over £1 before the next piece of news. What will it be IBS phase II or Covid phase II results..???

Yes google search Blautix reddit